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Abstract:  Shiga toxin (Stx) produced by the invasive Shigella dysenteriae  serotype 1   
(S. dysenteriae1) causes gastrointestinal and kidney complications. It has been assumed 
that Stx is released intracellularly after enterocyte invasion by S. dysenteriae1. However, 
there is little information about Stx distribution inside S. dysenteriae1-infected enterocytes. 
Here, we use intestinal epithelial T84 cells to characterize the trafficking of Stx delivered 
into the cytosol, in ways that mimic aspects of S. dysenteriae1 infection. We find that 
cytoplasmic Stx is transported into nucleoli. Stx nucleolar movement is carrier-  and 
energy-dependent. Stx binding to the nucleoli of normal human enterocytes in vitro 
supports possible roles for nucleolar trafficking in toxin-induced intestinal pathology. 
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1. Introduction 
The illnesses caused by the Shiga toxin (Stx)-producing bacteria Shigella dysenteriae serotype 1  
(S.  dysenteriae1) can produce fever, fatigue, anorexia, watery and bloody diarrhea, and often 
progresses to dysentery and the hemolytic uremic syndrome [1–3]. Stx-related pathology has been 
intensively studied, because Shigellosis is a major cause of death of children in the developing   
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world [3,4]. Moreover, S. dysenteriae1  strains are often resistant to many drugs, can cause large 
epidemics and are not prevented or treated by currently-available vaccines [2–4]. 
S. dysenteriae1, which is ingested from contaminated food and water or transmitted from infected 
individuals, causes illness after colonization of the distal small intestine and colon. The bacteria invade 
the mucosa through M-cells, bypassing the epithelial cell barrier [5]. This microorganism secretes 
factors such as IpaB, which bind to caspase-1 and initiate phagosome lysis. This phagosome lysis 
allows bacteria to escape into the cytoplasm. The S. dysenteriae1 then multiply and disseminate into 
the neighboring intestinal epithelial cells (IEC) through the basolateral membrane [5,6]. Severe bloody 
diarrhea occurs more frequently in persons infected with strains that produce high amounts of Stx, in 
comparison to those that produce low levels [2,4], suggesting a positive correlation between the 
amount of toxin and the severity of gastrointestinal complications.  
Stx represents a family of so-called AB5  toxins. A pentamer of B subunits is responsible for 
receptor binding, while a catalytic A subunit possesses N-glycosidase activity and inhibits protein 
synthesis through specific removal of the adenine base at the 28S ribosomal RNA of eukaryotic 
ribosomes [7–9].  
Our knowledge of the mechanisms of Stx interaction with human enterocytes [1,7,8] is mainly 
based on studies of the interaction between the purified holotoxin or its recombinant B-subunits (StxB) 
in IEC models. This approach has several limitations. For instance, the interaction of Stx with its 
receptor, a glycosphingolipid globotriaosylceramide (Gb3), which has been elucidated in these cell 
models, probably does not occur in human disease because Gb3 expression in normal enterocytes is 
undetectable in physiological conditions [10–14]. Moreover, the potential contribution of bacterial 
infection to the mechanisms of Stx endocytosis and intracellular trafficking has been poorly 
incorporated in these simplistic in vitro IEC cell models. The mechanisms whereby Stx interacts with 
human enterocytes, the ways in which toxin is distributed and trafficked intracellularly in these cells, 
and the ways in which Stx mediates changes in cellular signal transduction pathways in the context of 
S. dysenteriae1 infections have not been adequately characterized.  
Because S. dysenteriae1 are invasive, Stx is presumably released into the cytoplasm of enterocytes. 
We now characterize the mechanism for intracellular trafficking of Stx delivered into the cytoplasm of 
the human intestinal epithelial T84 cell model, as it might occur in S. dysenteriae1 infection. We show 
that Stx, when released into the cytoplasm, is transported into the nucleoli. This nucleolar trafficking 
of Stx is specific, since neither B-subunit of Cholera toxin (CTB) nor 40 KDa dextran, when delivered 
into the cytoplasm, enter the nucleoli. Stx nucleolar uptake is not due to diffusion, but rather is an 
active carrier-dependent process. We discuss the ways in which this newly characterized Stx nucleolar 
trafficking pathway might contribute to S. dysenteriae1-induced intestinal diseases. 
2. Results and Discussion 
2.1. Stx delivered into the cytoplasm appears in nucleoli of IEC 
To characterize the distribution of Stx released into the cytoplasm of IEC, as a model for   
S. dysenteriae1 infection, we used  a digitonin-based cell membrane permeabilization technique. 
Digitonin is widely used to deliver viral proteins into the cytosol and has been used to analyze Toxins 2010, 2 
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intracellular trafficking of viral proteins [15,16]. As reported, digitonin selectively permeabilizes 
cellular membranes rich in cholesterol, as is true for the plasma membrane (PM), while intracellular 
organelle membranes with relatively low cholesterol content, including the nuclear envelope, remain 
intact [17,18]. Incubation of PM-permeabilized T84 cells with fluorescently-labeled Stx (0.2 µg/mL) 
led to the accumulation of Stx in nucleoli in ~90% of these cells (Figure 1a). 
Figure 1. Localization of Stx and StxB to the nucleoli of intestinal epithelial T84 cells and 
human colonic tissue. (a)  Stx-Alexa 488 (green) appears in the nucleoli of   
PM-permeabilized confluent T84 cells; blue: nuclear staining by Hoechst dye; arrows point 
to the nucleoli filled with Stx-Alexa 488. (b)  Recombinant StxB-Alexa 568 (red) is 
delivered from cytoplasm into the nucleoli of PM-permeabilized confluent T84 cells; blue: 
nuclear staining by Hoechst dye. (c) T84 cells immunostained with an antibody against the 
nucleolar protein nucleolin (red). (d)  Same  cells as in c  stained with StxB-Alexa 488 
(green), confirming StxB nucleolar localization. (e)  Normal human colonic tissue 
immunostained with StxB-Alexa 488 (green) indicates the presence of StxB binding sites 
in nucleoli of crypt epithelial cells; red: β-catenin; blue: Hoechst nuclear stain; arrows in 
the magnified insert point to the nucleoli inside the nuclei filled with StxB-Alexa 488.  
(f) StxB-Alexa 568 (red) is accumulated in the nucleoli of PM-permeabilized T84 cells, 
while CTB-fluorescein (green) is present in cytoplasm and membranes but not in nucleoli. 
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The B-subunit of Stx has been shown to be necessary and sufficient for Stx retrograde trafficking  
[7–9,19,20]. To test whether StxB is sufficient for toxin movement into subcellular compartments 
including the nucleolus, PM-permeabilized T84 cells were exposed to recombinant StxB. 
Fluorescently-labeled StxB (0.5 µg/mL) delivered into the cytoplasm of T84 cells appeared in nucleoli 
(Figure 1b), indicating that StxB is sufficient for the toxin to enter the nucleoli. Moreover, the pattern 
of StxB fluorescence in nucleoli was similar to the pattern of staining for the endogenous nucleolar 
protein nucleolin (Figure 1c, d). Thus, StxB delivered into the cytoplasm accumulates in the nucleoli 
of T84 cells. 
Stx nucleolar accumulation in IEC does not appear to be limited to T84 cells. When we stained 
normal human colon samples with fluorescently-labeled StxB, nucleoli in both surface (data not 
shown) and crypt epithelial cells (Figure 1e) were labeled by StxB. Stx-binding sites appear to be 
present in nucleoli of normal mammalian enterocytes.  
2.2. Transport into the nucleoli displays specificity for Stx 
Another well-studied member of the AB5 toxin family is a cholera toxin (CT). The B-pentamer of 
CT (CTB) binds to the glycosphingolipid receptor GM1  that is expressed at the apical surface of 
enterocytes. Then the  toxin-receptor complex is internalized by retrograde pathways [21]. To test 
whether CTB can also be transported into the nucleoli upon its cytoplasmic delivery, permeabilized 
T84 cells were simultaneously exposed at 37  ºC  to both fluorescently-labeled StxB and CTB   
(0.5 µg/mL). CTB appeared mostly in the cytoplasm and at the apical cell surface where it binds to its 
receptor GM1. CTB did not accumulate in nucleoli of T84 cells (Figure 1f). Nucleolar trafficking is 
thus not a common feature of all AB5 toxins, but is rather a characteristic of Stx. 
2.3. StxB moves into nuclei as a pentamer 
Upon production by bacteria, the B-subunits of Stx spontaneously form pentamers in solution. 
These B-pentamers are the functional units in Stx retrograde trafficking [7–9]. In our   
PM-permeabilized cell model, the StxB is delivered from the cytoplasm into the nucleoli. However, it 
is conceivable that the StxB pentamer experiences partial degradation by some cytosolic enzyme and 
that B-subunit fragments might thus contribute to  the observed nucleolar toxin accumulation. To 
determine whether intact StxB pentamers  move into the nuclei and accumulate in nucleoli,   
PM-permeabilized T84 cells were exposed to StxB for 1 h at 37 ºC and then lysed. Total cell lysate 
was subjected to non-denaturing gel electrophoresis. The appearance of StxB in total cell lysate was 
detected by Western blot analysis using monoclonal antibody against StxB. Additionally, to explore 
the possibility that cytoplasmic enzymes might cleave StxB, total cell lysate and nuclear lysate from 
T84 cells were separately incubated with recombinant StxB, and again subjected to non-denaturing  
gel electrophoresis.  
The StxB that accumulated inside the permeabilized T84 cells and StxB after in vitro incubation 
with total cell or nuclear lysate (Figure 2b) appeared on Western blots as a single band of the same 
molecular weight as purified recombinant StxB identified by Coomassie Blue staining (Figure 2a,  
line 2). This is smaller than Stx holotoxin band (Figure 2a, line 1). As a control for the antibody 
sensitivity to StxB monomer, recombinant StxB was subjected to SDS-PAGE under reducing Toxins 2010, 2 
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conditions followed by immunoblotting (Figure 2c), which showed that StxB exists as a monomer 
only. In the cell and nuclear lysates, StxB was similar in size to the recombinant protein on   
non-denaturing gels (Figure 2a). No bands smaller than the StxB pentamer were detected, indicating 
that StxB inside the cells is probably not cleaved. These data demonstrate that StxB exists as a 
pentamer in the cytoplasm and the nuclei of intestinal epithelial cells, and that pentameric StxB is 
probably the form that enters nucleoli. 
Figure 2. Non-denaturing gels demonstrate that StxB pentamer is present in the nucleoli 
and cytoplasm of T84 cells.  (a)  Coomassie Blue staining, lane  1:  Stx holotoxin   
(10 µg/lane); lane 2: recombinant StxB pentamer (5 µg/lane). (b) Western blot analysis 
using mAb against StxB, lane 3: StxB from the lysate of permeabilized T84 cells exposed 
to StxB for 1 h; lane 4: StxB after incubation with T84 cell lysate; lane 5: StxB after 
incubation with T84 cell nuclear fraction. (c) Recombinant (100 ng/lane) StxB monomer 
on Western blot following SDS-PAGE. In lanes 3–5, the molecular weight of StxB is the 
same as recombinant StxB pentamer in lane 2. Images in b  and  c  were obtained by 
scanning two membranes simultaneously. Neither Coomassie Blue staining nor Western 
blot detected any StxB-positive protein bands with molecular weight lower than the StxB 
pentamer in non-denaturing conditions. 
 
2.4. StxB does not enter the nucleus by diffusion 
Nucleolar protein trafficking includes transport into the nucleus that can occur by two different 
mechanisms: diffusion or active transport through nuclear pores [22]. The nuclear pore complex (NPC) 
contains a ~10 nm channel that allows nonselective passive diffusion of small molecules across the 
nuclear envelope [23]. Small proteins with molecular weights of less than 30–40 kDa can diffuse 
through the NPC and equilibrate between nucleus and cytoplasm, although larger molecules cannot 
diffuse across this channel [24]. The molecular weight of Stx holotoxin is ~70 kDa, significantly above 
this diffusion limit. However, molecular modeling demonstrates that the toxin dimensions are defined 
by the size of the B-pentamer (molecular weight ~38 kDa) [1,9]. Since 40 kDa molecules can move 
through the nuclear pore either by a transporter-mediated process or diffusion, we first consider the 
possibility that StxB movement from the cytosol into the nucleus might occur by diffusion. 
To study the mechanism of StxB nuclear transport, we incubated PM-permeabilized T84 cells at  
37 °C with both StxB (0.5 µg/mL) and 40 kDa dextran (1 µg/mL), which is transported into the Toxins 2010, 2 
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nucleus exclusively by diffusion [25]. We compared the patterns and rates of nuclear accumulation of 
these two molecules.  
As shown in Figure 3a, after 5 min of incubation, StxB is present in nucleoli, whereas 40 kDa 
dextran is present only in the cytoplasm (present at undetectable levels in nucleus).  
Quantifying StxB and 40 kDa dextran fluorescence intensities over time in nucleoli (Figure 3b) 
showed that at a given solution concentration (0.5 µg/mL), the StxB fluorescence intensity in nucleoli 
reached saturation ~15 min after StxB was added. In contrast, the average nucleolar fluorescence 
intensity from administration of 40 kDa dextran (solution concentration 1 µg/mL) barely reached a 
level above background at this time. The lack of dextran detection in nucleoli was not due to lower 
fluorescence intensity of TMRE or less detection sensitivity; the fluorescence from dextran 
accumulated in cytoplasm reached saturating levels ~5 min after incubation started (Figure 3a). The 
large hydrodynamic radius of the 40 kDa dextran molecules is likely to slow diffusion through the 
nuclear pore, as has been shown previously [26]. Significant amounts of dextran appear in the nucleus 
only after ~40 min of incubation, indicating that StxB and 40 kDa dextran use different mechanisms of 
nuclear transport. Thus, StxB does not appear to travel to nucleoli simply by diffusion across   
nuclear pores.  
To further prove that Stx movement from the  cytosol into the nucleus and nucleoli is not via 
diffusion, T84 cells were treated with the detergent CHAPS, which specifically permeabilizes the 
nuclear membrane [27,28] and enables molecules to diffuse freely between cytoplasm and 
nucleoplasm. Accumulation within the nucleus and nucleolus under these conditions can only occur 
through binding to nuclear or nucleolar components. StxB accumulated in the nucleoli of   
CHAPS-permeabilized T84 cells in ways similar to the accumulation into cells permeabilized by 
digitonin treatment. CHAPS did not cause back-diffusion of StxB into the cytoplasm (data not shown). 
These results add to evidence that diffusion is not responsible for appearance of StxB in nucleus  
and nucleolus. 
The transport of proteins and RNAs through the gated channels in the NPC is a highly selective and 
signal-mediated process [22,29]. Wheat germ agglutinin (WGA) can bind to O-linked glycoproteins of 
the NPC [30] and inhibit translocation of macromolecules through the nuclear pore without altering 
free diffusion [31,32]. Pretreatment of T84 cells with WGA for 30 min (Figure 3c) significantly 
inhibited StxB nucleolar accumulation. 50 µg/mL WGA virtually abolished StxB nuclear transport 
(Figure 3d), compared to control (Figure 1b). However, 50 µg/mL WGA did not prevent nuclear 
accumulation of 10 kDa dextran (Supplemental Figure  1). Taken together, these data provide 
additional evidence that StxB is transferred across nuclear pores by carrier-dependent processes and 
not by diffusion.  
 Toxins 2010, 2 
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Figure 3. StxB nucleolar trafficking is not due to diffusion through the nuclear pore 
complex. (a) representative confocal image of PM-permeabilized T84 cells incubated with 
both StxB-Alexa 488 (0.5 µg/mL; green) and 40 kDa dextran conjugated with TMRE  
(1 µg/mL; red). StxB accumulated in nucleoli, while dextran was present exclusively in the 
cytoplasm.  Blue:  Hoechst nuclear labeling;  (b)  The kinetics of StxB nucleolar 
accumulation (red squares) compared to 40 kDa dextran (black dots) depicted in a. The 
data presented are mean ± SEM of average fluorescence intensity measured in grey levels 
(g.l.) of 10 nucleoli from 3 different experiments. StxB accumulated significantly faster in 
the nucleoli than the same molecular weight dextran, achieving a half saturation level in  
~6 min, while the amount of dextran did not reach saturation in the nucleoli even after  
240 min;  (c)  representative confocal image of  T84 cells pretreated for 30 min with   
50 µg/mL WGA labeled with fluorescein (green), which prevented transport of StxB-Alexa 
568 (red) into nuclei and nucleoli; (d) Pretreatment of T84 cells with WGA significantly 
inhibited StxB nuclear accumulation in a concentration dependent manner. The amount of 
nucleolar StxB was calculated from confocal images taken 15 min after StxB cytoplasmic 
delivery.  The data presented are mean ± SEM of average fluorescence intensity  
measured in g.l. 
 
2.5. StxB-subunit nucleolar uptake is carrier dependent 
Transport of many proteins into the nucleus is directed by short amino acid sequences known as 
nuclear localization signals (NLS), which specifically interact with the NPC. Most well-characterized 
NLS contain a short stretch of basic residues, often flanked by a proline or glycine. Such a prototypical 
NLS  for  the  SV40 large T-antigen is necessary and sufficient to direct the T antigen from the 
cytoplasm to the nucleus  [33].  However, comparison of  the  StxB sequence with all known NLS 
sequences [34] using the BLAST database did not identify any area with a high homology. Because Toxins 2010, 2 
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StxB does not have an identified NLS, and because StxB does not diffuse through the nuclear pore 
(Figure 3), we hypothesized that some protein that has a NLS and can shuttle between the cytoplasm 
and nucleus might bind StxB in the cytoplasm and carry it into the nucleus and nucleoli. It has been 
shown [35,36] that nuclear import of many NLS-bearing proteins requires cytosolic factors that are 
sensitive to alkylation by N-ethyl-maleimide (NEM). Thus, we examined the effect of NEM on StxB 
nucleolar uptake. Pretreatment of permeabilized T84 cells with 1 mM NEM for 10 min decreased the 
amount of StxB in nucleoli by almost 75% of control values (Figure 4a). These data are consistent with 
the idea that a NLS-bearing protein might be involved in StxB nuclear/nucleolar trafficking.  
Figure 4. StxB nucleolar trafficking is nuclear localization signal-dependent, but is 
transcription independent. (a) NEM pretreatment (1 mM for 30 min) significantly  inhibits 
StxB nucleolar accumulation compared to levels found in control non-treated cells   
(*p < 0.05, n = 265 nucleoli). CHAPS permeabilization of NEM-treated cells yielded 
levels of StxB nucleolar accumulation that were significantly greater than those of cells 
treated with NEM alone, but less than those of control cells that received neither treatment 
(** significant changes compared to control and to NEM treatment, p < 0.05,   
n = 106 nucleoli). The amount of StxB in nucleoli was calculated from 8-bit confocal 
fluorescence images as described in methods and expressed in g.l. (b)  Representative 
immunofluorescence image of T84 cells pretreated with 5 µg/mL ActD, which did not 
retain nucleolin (red by Alexa 568 secondary antibody) in nucleoli. (c) The same cells were 
still able to transport StxB-Alexa 488 (green) into the nucleoli. 
 
To test whether NEM treatment blocks further StxB binding by modifying the presumed nucleolar 
StxB receptor, we permeabilized the NEM-pretreated cells with CHAPS and quantified the relative 
amount of nucleolar Stx1B. The CHAPS treatment partially reversed NEM inhibition of nucleolar 
StxB accumulation (Figure 4a). StxB nucleolar binding sites are thus rather not inactivated by NEM. 
During these NEM plus CHAPS experiments, StxB nucleolar intensity did not reached the levels Toxins 2010, 2 
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achieved under control conditions (Figure 4a). Carrier-dependent StxB transport from cytoplasm into 
nucleoli under control conditions is thus likely to be faster than CHAPS-enabled toxin diffusion 
through the nuclear envelope in NEM-treated cells. 
2.6. StxB nucleolar accumulation is independent of transcription 
Mammalian nucleoli are large (up to 5–10 µm) structures that disassemble in late prophase and 
reform in telophase in response to transcription of ribosomal DNA [37]. There are three structurally 
distinguishable nucleolar constituents: fibrillar centers, dense fibrillar components, and granular 
components, as observed by electron microscopy [38,39]. Transcription likely occurs near the border 
of the fibrillar center and dense fibrillar components. Accumulation of several proteins in nucleoli, 
including accumulation of rRNA binding proteins, is transcription-dependent. We thus determined 
whether StxB  nucleolar import was modified by actinomycin D (ActD) treatments that  block 
transcription [40]. T84 cells were incubated for 3 h with either 0.05 or 5 µg/mL ActD in order to 
inhibit the activity of either RNA polymerase I alone or both RNA polymerase I and II, respectively. 
The effectiveness of ActD treatment was assessed by dramatic treatment-induced redistribution of the 
endogenous nucleolar protein nucleolin [41], which became  excluded from nucleoli  as predicted 
(Figure 4b). However, neither low nor high doses of ActD prevented StxB movement into the nucleoli 
(Figure  4c). Quantification of the StxB average fluorescence intensity reflects StxB nucleolar 
quantities, and did not change after ActD treatment in comparison to control treatment, indicating that 
StxB nucleolar accumulation is independent of DNA transcription. 
2.7. StxB is actively transported across the nuclear membrane 
Crossing of the NPC is generally an energy- and temperature-dependent process [42–44]. To test 
whether nuclear transport of StxB is temperature dependent, T84 cells where chilled to 4 ºC for 1 h in 
cold serum free media prior to the exposure to StxB for 15 min.  
Low temperature significantly inhibited nucleolar transport of StxB (Figure 5c–e) compared to 
levels observed in control cells incubated at 37 ºC (Figure 5a and b). The StxB nucleolar intensity 
decreased from 204 ± 36 g.l. in control to 38 ± 7 g.l. at 4 ºC (Figure 5e). Moreover, StxB fluorescence 
levels fell below the limit of detection in ~40% of cells at 4 ºC. Since passive diffusion is proportional 
to the absolute temperature, a drop from 37 ºC to 4 ºC would have been expected to exert a much 
smaller effect [45]. These results provide additional support for the idea that import of StxB does not 
occur by passive diffusion.  
Nuclear import often involves interaction between cargo and the members of the importin family of 
carrier molecules, which contains more than 20 human isoforms [46]. This import requires energy. In 
many cases, at least part of the energy requirement is linked to the small GTPase Ran, which catalyzes 
the release of cargo from the importin complex inside the nucleus [47,48]. Incubation of T84 cells at 
37  ºC  with GTP-γ-s, a nonhydrolyzable GTP analog, for 1  h prior to StxB,  significantly and   
dose-dependently reduced both the number of cells able to transport StxB into nucleoli and the amount 
of StxB in nucleoli. The percent of cells able to transport StxB into nucleoli significantly decreased  
(p < 0.05) from 94 ± 6% in control to 34 ± 10% in the presence of 300 µM GTP-γ-s (Figure 5f). The Toxins 2010, 2 
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amount of nucleolar StxB  (Figure 5g) also significantly decreased (p  <  0.05) in the presence of   
300 µM GTP-γ-s (156 ± 26 g.l.) compared to that in control (247 ± 19 g.l).  
It has recently been shown that ATP depletion causes an inhibition of Ran-dependent nuclear 
protein transport due to dissociation of ATP-dependent Ran-GDP complexes  [49,50]. Upon ATP 
depletion, by 2 h combined pretreatment of T84 cells at 37 ºC with 24 µM rotenone and 15 mM 
deoxyglucose [41], the relative amount of StxB in the nucleoli was significantly different (p < 0.05) in 
control (204 ± 36 g.l.) to in ATP-depleted cells (84 ± 27 g.l.) (Figure 5e), These data show that Stx 
translocation across the nuclear membrane is an active, energy-dependent process. 
Figure 5. StxB nucleolar transport is temperature and energy-dependent. (a) An example 
of fluorescent StxB (green) accumulated in the nucleoli of permeabilized T84 cells after  
15 min of incubation with StxB at 37 ºC. (b) The corresponding bright field image of a;  
(c) Cells incubated with StxB (green) for 15 min at 4 ºC. (d) The corresponding bright field 
image. White arrows point to nucleoli. (e) The relative amount of StxB in the nucleoli of 
T84 cells calculated from fluorescence images at 37 ºC (1), at 4 ºC (2) and after ATP 
depletion at 37 ºC (3). Low temperature and ATP depletion significantly decrease the StxB 
nucleolar amount compared to control cells at 37 ºC (p < 0.05, n = 60 nucleoli for each 
group). (f) GTP-γ-s treatment significantly decreases % of cells with nucleolar StxB in a 
dose-dependent manner compared to non-treated control cells (*p < 0.05, n = 311 cells for 
each condition from 10 fields in 3 different preparations). (g) GTP-γ-s treatment (0.3 mM) 
significantly decreases the amount of nucleolar StxB compared to non-treated control cells 
(* p < 0.05, n = 178 cells from 10 fields in 3 different preparations). 
 
The distribution of Stx inside the intestinal epithelial cells from patients infected with invasive  
S. dysenteriae1 has not been characterized. Also, while the role of Stx in intestinal epithelial pathology 
due to Shigellosis is assumed, the direct impact of Stx itself on intestinal epithelial pathology has not 
been determined. Here, using a T84 cell model, we define the intracellular trafficking and distribution 
of Stx delivered into the cytoplasm of IEC as it potentially occurs in S. dysenteriae1 infection. Our Toxins 2010, 2 
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data show that a cytoplasmic pool of Stx can be transported into the nucleoli of IEC and that StxB is 
sufficient for this trafficking. This process is efficient; virtually 100% of PM-permeabilized T84 cells 
exposed to Stx or StxB displayed toxin in their nucleoli.  
Our conclusion that nucleolar uptake of StxB does  not occur by diffusion but rather  via a   
carrier-dependent mechanism is based on several lines of experimental evidence, including: (1) A 
well-characterized nuclear protein import model based on PM-permeabilization by digitonin allows the 
maintenance of the nuclear membranes in a state competent for signal-dependent translocation through 
the nuclear pore [17]. Thus, the nuclear and consequently nucleolar appearance of Stx was not due 
solely to lysis of the nuclear envelope by detergent. (2) StxB nucleolar transport was significantly 
faster than that of diffusion of similarly-sized 40 kDa dextran [25]; (3) a lectin WGA, which inhibits 
active nuclear transport but not diffusion, by direct binding to acetylglucosamine-bearing nucleoporins 
[30], significantly inhibited StxB nucleolar accumulation in a dose-dependent manner; (4) StxB 
nucleolar accumulation is temperature and energy-dependent, being inhibited by low temperature, 
ATP depletion and GTP substitution. Taken together, these data demonstrate that StxB is actively 
translocated across the NPC to enter the nucleus. 
Nucleolar accumulation of Stx is specific, because double-labeling of T84 cells with CTB and StxB 
at 37 ºC showed that, even after 5 h of toxin exposure, only StxB was in the nucleoli, while CTB was 
present in the cytoplasm and in the membrane structures in the same cells.  
The nuclear import of large molecules is an energy-dependent process mediated by transport 
factors, many of which belong to the family of importins. Importins bind to cargo proteins in the 
cytoplasm, aid their translocation through NPCs, and then release them in the nucleus. However, to be 
recognized by these transport factors, the cargo proteins must contain one or more NLS sequences to 
direct them into nucleus. About 10 different NLS have been identified, including the classical 
PKKKPKV sequence from SV40 T-antigen and XPR repeats in Herpes virus type I US11 protein [37]. 
The StxB amino acid sequence did not have any known NLS. This allowed us to hypothesize that in 
the cytoplasm, StxB may bind to another protein that bears a NLS and carries StxB through the NPC. 
Our experiments using NEM, which inhibits nuclear import of NLS-bearing proteins [35,36] 
demonstrate that StxB nucleolar trafficking significantly decreased in a manner consistent with the 
involvement of a NLS-bearing protein-carrier. 
Many nucleolar proteins, which are involved in ribosomal biogenesis, are able to shuttle between 
cytoplasm and nucleus. There are often several NLS on one such molecule. Moreover, to accumulate 
in the nucleoli, such proteins also need so-called nucleolar retention signals [50,51]. However, no 
common amino acid sequence that targets all nucleolar proteins to nucleoli has been identified. Rather, 
individual sequences on each molecule serve this role, as in the case of several viral proteins [52]. 
Binding to some nucleolar protein with a NLS might explain both StxB translocation across the 
nuclear envelope and its nucleolar retention. This hypothesis is supported by our experimental 
observation that StxB binds to nucleoli of human enterocytes as detected by immunofluorescence. This 
data also supports our hypothesis that Stx is transported from the cytoplasm to the nucleoli in vivo in 
the course of S. dysenteriae1–induced intestinal disease. 
Recent observations in monocyte-derived cells show that StxB can co-localize with the nucleolar 
marker nucleolphosmin/B23 [53] and can  be co-precipitated with B23 [53,54]. However, our Toxins 2010, 2 
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preliminary data do not support such a direct interaction between StxB and B23 in IEC. We believe 
that the Stx nucleolar carrier has not been identified.  
Stx nuclear/nucleolar appearance has been reported previously. Trafficking of Stx holotoxin or 
StxB in human astrocytoma and ovarian carcinoma cells was identified either to the  ER/nuclear 
envelope or the Golgi/ER, depending on the Gb3 fatty acid isoform present [55]. Nuclear targeting 
appeared preferentially with Gb3 containing shorter chain fatty acids. The authors proposed that the 
fatty acid chain—dependent traffic of Gb3 from the cell surface to the ER/nuclear membrane provides 
a specific signal transduction pathway for Stx/StxB. In contrast, our data gained in permeabilized T84 
cells and also in immunostained human colonic tissue sections showed that the presence of Gb3 and 
the formation of toxin-Gb3 complexes are not necessary for StxB nucleolar localization. Examination 
of Stx distribution in samples of intestinal tissue from patient infected with S. dysenteriae1 is 
necessary to determine whether Stx trafficking from cytoplasm into the nucleoli takes place in human 
disease. If Stx appears in the nucleoli of enterocytes due to S. dysenteriae1 infection, the role of the 
nucleolar pool of toxin in disease should be sought with vigor.  
3. Conclusions 
Here we have characterized a newly-recognized Stx pathway from the cytoplasm to nucleoli of IEC. 
We also showed that nucleoli of human enterocytes have Stx binding sites, indicating that this newly-
described Stx trafficking pathway might be relevant for S. dysenteriae1-induced intestinal pathology. 
Stx nucleolar transport is an active and a carrier-dependent process and is specific for Stx compared to 
other AB5 toxins.  
4. Materials and Methods 
4.1. Materials 
Purified Stx and recombinant StxB (GRASP Center, Tufts-New England Medical Center, Boston, 
MA), were labeled with either Alexa Fluor-488, or Alexa Fluor-568 reactive fluorescent dyes 
following the manufacturer’s protocol (Invitogen, Molecular Probes, Eugene, OR). Fluorescein 
conjugated wheat germ agglutinin (WGA), tetramethylrhodamine (TMRE) labeled 40 kDa and 10 kDa 
dextran, propidium iodide, recombinant Annexin V conjugated with Alexa 488 fluorescent dye, and 
Alexa 488 or 568 conjugated secondary antibodies  were from Invitrogen. Purified cholera toxin   
B-subunit (CTB) conjugated with fluorescein was from List Biological Laboratories, Inc. (Campbell, 
CA). Digitonin, NEM, ActD,  rotenone, TMRE, deoxyglucose, CHAPS  and monoclonal antibody 
against ß-catenin were obtained from Sigma. Polyclonal anti- nucleolin antibody was a generous gift 
from Joseph Gall (Carnegie Institution of Washington, Baltimore, MD). Monoclonal CD77 antibody 
against Gb3 was from Seikagaku America (Falmouth, MA). Monoclonal antibody against StxB was a 
generous gift from Cheleste Thorpe (Tufts-New England Medical Center, Boston, MA). 
4.2. Cell culture 
Since normal human enterocytes lack Gb3, we chose human Cl
--secreting colon carcinoma T84 
cells as a model to study the interaction of Stx with IEC because this cell line is considered Gb3–free Toxins 2010, 2 
 
1330 
[12–14,56].  The T84 cells  were maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 25 mM NaHCO3, 10 mM HEPES, 50 IU/mL penicillin, 50 μg/mL streptomycin, 
and 10% fetal bovine serum in a 5% CO2 incubator at 37 ºC. For experiments, the cells were grown on 
plastic Petri dishes or glass coverslips and were used 1–5 days after reaching confluence. 
For permeabilization, cells were treated with 30 µg/mL digitonin for ~ 3 min at 37 ºC in serum free 
media containing 250 mM sucrose as it has been described in detail [26]. With these conditions, the 
cells were permeabilized without significant cell damage as checked by visible changes in cell shape, 
propidium iodide labeling and DNA-laddering assays.  
4.3. Cell lysate preparation and protein electrophoresis 
For total lysate preparation, cells were washed 3 times with ice-cold PBS and lysed in 1 mL of 
buffer containing 60 mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 3 mM KCl, 5 mM EDTA, 3 mM 
EGTA, 1mM Na orthovanadate, 50 mM NaF, 1% Triton X-100 and protease cocktail inhibitor   
(#P8340;  Sigma) by sonication 3–4 times for 20 s each. Insoluble cell debris was removed by 
centrifugation for 20 min at 12,000 x g and the supernatant was used as total cell lysate.  
Large-scale preparation of nuclear extracts from T84 cells was performed as described previously 
[57]. Nuclear pellets were washed twice with PBS and resuspended in buffer A (50 mM HEPES,  
pH 7.4, 50 mM KCl, 0.1 mM EDTA, 1 mM DDT, 10% glycerol and protease cocktail inhibitors 
(Sigma)) plus 300 mM (NH4)2SO4. The resuspended nuclei were rocked for 30 min at 4 ºC followed 
by centrifugation at 350,000 x g for 10 min.  
Both total cell lysates and nuclear extracts were immediately incubated with 0.5 µg/mL StxB by 
rocking for 1  h at room temperature or overnight at 4
 ºC  and then were analyzed using Native   
(non-denaturing) PAGE (11%) according to Laemmli [58]. After electrophoresis, proteins were 
visualized with Coomassie Blue or transferred to nitrocellulose membrane for Western blot analysis 
with an antibody against StxB. 
4.4. Immunofluorescence microscopy 
Cell model: In experiments measuring Stx or StxB accumulation in nucleoli, control or pretreated 
monolayers were permeabilized for 3 min, washed with serum-containing media to remove digitonin, 
and incubated with fluorescently-labeled Stx (0.2 µg/mL) or StxB (0.5 µg/mL) at 37 ºC for 15 minutes, 
after which free fluorescent toxin was washed away by serum-containing media. Cell monolayers were 
examined by confocal imaging followed by quantitation of toxin nucleolar fluorescence intensity.  
In immunofluorescence experiments, after StxB treatment (0.5 µg/mL), cells were fixed for 10 min 
in 3% paraformaldehyde, permeabilized with 0.1% CHAPS, treated with a mixture of 2% bovine 
serum albumin and 15% fetal calf serum to prevent non-specific binding, and incubated for 1 h at room 
temperature with primary Ab followed by 1 h incubation with fluorescently-labeled secondary Ab. 
Control and treated cells for each experiment were from the same passage and had equal cell density.  
To quantify the relative amount of fluorescent toxin that was transported into the nucleoli, 8-bit 
confocal images of the cells were generated using a Zeiss 510/META confocal microscope, as we 
described in detail [56]. Optical sections from 15 different randomly chosen areas with multiple cells 
in each control (n = 3) and experimental monolayer (n = 3 for each type of treatment) were collected. Toxins 2010, 2 
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Images  were inclusively thresholded to eliminate background and ensure no pixels with intensity 
higher than 255 grey levels (g.l.) were included in the analysis. The average fluorescence intensity in 
g.l. that corresponds to the amount of fluorescent StxB for each nucleolus in each image was measured 
(MetaMorph, Universal Imaging, West Chester, PA).  The average amount of StxB per nuclei in 
control monolayers was calculated as mean g.l. ± S.E.M and set at 100% ± S.E.M. The amount of 
nucleolar toxin in experimental monolayers was calculated as percentage relative to the average 
amount of toxin in controls.  
In experiments measuring StxB and 40 kDa dextran nucleolar accumulation over time, T84 cells 
were mounted in a temperature controlled 37 ºC perfusion chamber, as described previously [59]. The 
monolayers were perfused for 3 min with serum free solution containing digitonin plus StxB-Alexa 
488 and 40 kDa dextran-TMRE. Then cells were perfused with complete growth media containing 
serum. A single confocal optical section through the middle of the majority of cells in the field of view 
was taken for red and green emission channels simultaneously each 30 sec starting 2 min before 
digitonin perfusion and continuing for the next 12 min. After that time (to avoid possible bleaching), 
images from the same optical section were taken every 2 min until the end of the experiment. The 
relative amounts of StxB and 40 kDa dextran in nucleoli for each time point were calculated from  
8-bit images. 
Human normal colonic tissue: Frozen 20 µm thick samples of surgically removed, normal human 
colonic tissue were obtained from the Johns Hopkins Colorectal Cancer Registry with JHM-IRB1 
granted exemption. Tissue samples were fixed, permeabilized with 0.1% saponin or 0.1% CHAPS and 
immunostained with fluorescently conjugated StxB and mAb against ß-catenin. Images were obtained 
using a Zeiss 510/META confocal microscope, as described above. 
4.5. Statistics 
Data presented are mean ± standard error of the mean (S.E.M.).  Statistical significance was 
determined using the Student’s t test, and p values ≤ 0.05 were considered statistically significant. 
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Appendix 1. WGA does not inhibit nuclear transport of 10 kDa dextran. Confocal image 
of T84 cells pretreated for 30 min with 50 µg/mL WGA (not conjugated to a fluorescent 
dye) and exposed for 5 min to 1 µg/mL 10 kDa dextran-TMRE. Dextran is present in 
nuclei and in cytoplasm of T84 cells. 
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